Mass Spectrometry for Diabetic Nephropathy Monitoring: New Effective Tools for Physicians

Figure 2

MALDI mass spectra of urine samples from: (a) control subject, (b) diabetic patient, (c) nephropathic patient, and (d) diabetic-nephropathic patient [31].

(a)

(b)

(c)

(d)